Passage Bio, Inc.

NASDAQ:PASG

0.596 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -102.062-136.125-185.386-112.232-45.634-12.77
Depreciation & Amortization 3.7213.6791.5430.80.1340
Deferred Income Tax 2.7902.7780.6339.1410
Stock Based Compensation 10.92118.95432.69114.581.4540
Change In Working Capital 5.339-8.49111.4214.44-5.943-8.524
Accounts Receivables 00000.3980.212
Inventory 000000
Accounts Payables -2.79-5.4122.2014.5880.3980.212
Other Working Capital 8.129-3.0799.2199.852-6.739-8.948
Other Non Cash Items 1.0273.77310.0751.2590.9522.727
Operating Cash Flow -78.264-118.21-126.879-80.52-39.896-18.567
Investing Activities:
Investments In Property Plant And Equipment -0.146-5.274-25.642-1.646-1.693-2.543
Acquisitions Net 0380.500
Purchases Of Investments -129.432-157.835-202.546-266.05700
Sales Maturities Of Investments 194.815188.308182.37495.59700
Other Investing Activites -0-3-8-0.5-0.001-0.003
Investing Cash Flow 65.23725.199-45.814-172.106-1.693-2.543
Financing Activities:
Debt Repayment 000000
Common Stock Issued 0.1350.433166.656228.262175.60245.971
Common Stock Repurchased 0.1350.3040.8870.28400
Dividends Paid 000000
Other Financing Activities 0-0.0010.1670.208-0.76345.971
Financing Cash Flow 0.135-0.0010.167228.754175.60245.971
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -12.892-94.364-6.037-23.872134.01324.861
Cash At End Of Period 21.70934.601128.965135.002158.87424.861